Mylan would pay generic drug user fees, CEO tells Oppenheimer conference.
Executive Summary
MYLAN WOULD PAY GENERIC DRUG USER FEES, CEO Milan Puskar told the Oppenheimer & Co. Health Care Conference in New York City Nov. 8. Puskar commented that "generic industry new approvals have really slowed down" and suggested user fees to speed up the process. Mylan has "not received an approval for quite a while," Puskar noted.